Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D013313', 'term': 'Stress Disorders, Post-Traumatic'}], 'ancestors': [{'id': 'D040921', 'term': 'Stress Disorders, Traumatic'}, {'id': 'D000068099', 'term': 'Trauma and Stressor Related Disorders'}, {'id': 'D001523', 'term': 'Mental Disorders'}]}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'RETROSPECTIVE', 'observationalModel': 'OTHER'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 0}}, 'statusModule': {'whyStopped': 'Funding expired; no subjects enrolled as this was a retrospective chart review', 'overallStatus': 'WITHDRAWN', 'startDateStruct': {'date': '2005-09-01', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2017-09', 'completionDateStruct': {'date': '2005-09-30', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2017-09-12', 'studyFirstSubmitDate': '2005-10-03', 'studyFirstSubmitQcDate': '2005-10-03', 'lastUpdatePostDateStruct': {'date': '2017-09-14', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2005-10-05', 'type': 'ESTIMATED'}, 'primaryCompletionDateStruct': {'date': '2005-09-30', 'type': 'ACTUAL'}}, 'conditionsModule': {'keywords': ['antipsychotics', 'PTSD', 'posttraumatic stress disorder'], 'conditions': ['PTSD', 'Posttraumatic Stress Disorder']}, 'referencesModule': {'references': [{'pmid': '16013909', 'type': 'BACKGROUND', 'citation': 'Kozaric-Kovacic D, Pivac N, Muck-Seler D, Rothbaum BO. Risperidone in psychotic combat-related posttraumatic stress disorder: an open trial. J Clin Psychiatry. 2005 Jul;66(7):922-7. doi: 10.4088/jcp.v66n0716.'}]}, 'descriptionModule': {'briefSummary': "The main purpose is to show the percentage of patients taking antipsychotics with PTSD by looking at approximately ten year's worth of data from 1994 through 2004. We will also determine the type and dose of antipsychotics the patients received, and to determine how many of those patients had psychotic versus nonpsychotic symptoms. We will be obtaining this data from the VISN 7 Corporate Data Warehouse. We hypothesize that there has been an overall increase in antipsychotic use in patient's with PTSD over the last 10 years.", 'detailedDescription': "This study is a retrospective chart review of patients, at the Tuscaloosa VA Medical Center, who were, treated with antipsychotics as monotherapy or adjunctive therapy.\n\nThe data will be retrieved from a computerized list of patients treated at the TVAMC for PTSD from 1994-2004 Charts will be reviewed by looking at approximately ten year's worth of data. Charts will then be examined to determine what type of antipsychotics patients were prescribed, the dose and duration of the antipsychotics, and the presence or absence of documented psychotic symptoms."}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '19 Years', 'samplingMethod': 'NON_PROBABILITY_SAMPLE', 'studyPopulation': 'Chart review of Veterans on antipsychotics', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n1. Have a diagnosis of PTSD (309.81)\n2. Male or female patients at least 19 years of age\n\nExclusion Criteria:\n\n• None'}, 'identificationModule': {'nctId': 'NCT00233467', 'briefTitle': 'Characterization of the Use of Antipsychotics in Posttraumatic Stress Disorder During the Past Decade', 'organization': {'class': 'OTHER', 'fullName': 'Tuscaloosa Research & Education Advancement Corporation'}, 'officialTitle': 'Characterization of the Use of Antipsychotics in Posttraumatic Stress Disorder During the Past Decade', 'orgStudyIdInfo': {'id': 'TREAC Retro PTSD'}}, 'contactsLocationsModule': {'locations': [{'zip': '35404', 'city': 'Tuscaloosa', 'state': 'Alabama', 'country': 'United States', 'facility': 'Tuscaloosa VA Medical Center', 'geoPoint': {'lat': 33.20984, 'lon': -87.56917}}], 'overallOfficials': [{'name': 'Rebecca Seamans, PharmD', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Tuscaloosa Veterans Affairs Medical Center'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Tuscaloosa Research & Education Advancement Corporation', 'class': 'OTHER'}, 'responsibleParty': {'type': 'PRINCIPAL_INVESTIGATOR', 'investigatorTitle': 'ACSO for Research', 'investigatorFullName': 'Lori Davis, MD', 'investigatorAffiliation': 'Tuscaloosa Research & Education Advancement Corporation'}}}}